Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03934606 | Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model | completed | — | 1,488 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT04931069 | Correlation Between Complications After Pancreaticoduodenectomy and Microbiota(COMPAMIC) | completed | N/A | 39 | University Hospital, ToulouseOTHER | 1 | Apr 10, 2025 |
| clinicaltrials |
| NCT04229004 | A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer | completed | Phase 3 | 502 | Pancreatic Cancer Action NetworkOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT04602026 | The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer(RIOT) | completed | N/A | 66 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT04925284 | Study of XB002 in Subjects With Solid Tumors (JEWEL-101) | completed | Phase 1 | 269 | ExelixisINDUSTRY | 9 | Apr 4, 2025 | clinicaltrials |
| NCT04436679 | INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors(CaPaLong) | completed | — | 342 | University Hospital, LilleOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT02650804 | BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients | completed | Phase 2 | 45 | BPGbioINDUSTRY | 2 | Mar 26, 2025 | clinicaltrials |
| NCT04137289 | A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer | completed | Phase 1 | 110 | Boehringer IngelheimINDUSTRY | 8 | Mar 25, 2025 | clinicaltrials |
| NCT06111872 | Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography. | completed | Phase 2 | 90 | National University of MalaysiaOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06888401 | Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal | completed | — | 597 | Kathmandu University School of Medical SciencesOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT04484636 | PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)(PLATON) | completed | N/A | 400 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05340569 | Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.(DWI-PDAC) | completed | N/A | 40 | Laval UniversityOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT04668781 | Improvement of Care of Patients Undergoing Pancreaticoduodenectomy | completed | N/A | 92 | Helsinki University Central HospitalOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT01601808 | Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma(ViP) | completed | Phase 2 | 142 | University of LiverpoolOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT02457156 | Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy(PANasta) | completed | Phase 3 | 295 | University of LiverpoolOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT04247165 | Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.(LAPTOP) | completed | Phase 1 / Phase 2 | 55 | Herlev HospitalOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT05697198 | PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine(PREFER) | completed | — | 1,429 | Labcorp Corporation of America Holdings, IncINDUSTRY | 1 | Mar 6, 2025 | clinicaltrials |
| NCT02345408 | Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma | completed | Phase 1 | 54 | AmgenINDUSTRY | 2 | Feb 27, 2025 | clinicaltrials |
| NCT03058289 | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6(IT-01) | completed | Phase 1 / Phase 2 | 111 | Intensity Therapeutics, Inc.INDUSTRY | 2 | Feb 27, 2025 | clinicaltrials |
| NCT05303090 | Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer | completed | Phase 1 | 56 | Fudan UniversityOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT05131815 | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors | completed | N/A | 8 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 26, 2025 | clinicaltrials |
| NCT04631445 | Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer | completed | N/A | 32 | Translational Drug DevelopmentOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT02907099 | Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT03992664 | Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. | completed | N/A | 40 | Cyprus University of TechnologyOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT04386057 | LY3214996 +/- HCQ in Pancreatic Cancer | completed | Phase 2 | 52 | Kimberly Perez, MDOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04666688 | LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 / Phase 2 | 44 | PureTechINDUSTRY | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04805307 | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 | completed | Phase 1 | 176 | Keymed Biosciences Co.LtdINDUSTRY | 1 | Feb 12, 2025 | clinicaltrials |
| NCT05924789 | Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America(GASPAR) | completed | — | 120 | Latin American Cooperative Oncology GroupOTHER | 2 | Feb 12, 2025 | clinicaltrials |
| NCT02842749 | Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China | completed | Phase 4 | 61 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 10, 2025 | clinicaltrials |
| NCT01638533 | Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 2 | Feb 7, 2025 | clinicaltrials |
| NCT02349412 | Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers | completed | Phase 3 | 405 | Alliance for Clinical Trials in OncologyOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT05727319 | Advances in Imaging to Assess Response in Pancreatic Cancer (AIR-PANC)(AIR-PANC) | completed | — | 13 | NHS Greater Glasgow and ClydeOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT03161379 | GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer | completed | Phase 2 | 31 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT02089269 | Tumor Registry Pancreatic Cancer(AMETHYST) | completed | — | 2,325 | iOMEDICO AGINDUSTRY | 1 | Jan 30, 2025 | clinicaltrials |
| NCT04883775 | Study of a New Technique for Imaging Pancreatic Cancer | completed | Phase 1 | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06469138 | A Study to Investigate 14C-bemcentinib in Healthy Male Subjects(8479217) | completed | Phase 1 | 6 | BerGenBio ASAINDUSTRY | 1 | Jan 29, 2025 | clinicaltrials |
| NCT04662112 | Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma(NASOX) | completed | Phase 1 / Phase 2 | 40 | Asan Medical CenterOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT05462314 | Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies | completed | — | 24 | ViomeINDUSTRY | 1 | Jan 28, 2025 | clinicaltrials |
| NCT03154190 | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer | completed | N/A | 128 | Stanford UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT03699319 | CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 49 | David Bajor, MDOTHER | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06789224 | Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device(REMOVE) | completed | N/A | 136 | Lindis Bloodcare GmbHINDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT01821612 | Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer | completed | Early Phase 1 | 23 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT03153410 | Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas | completed | Early Phase 1 | 11 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT05031494 | A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers | completed | Phase 2 | 40 | Eucure (Beijing) Biopharma Co., LtdINDUSTRY | 2 | Jan 6, 2025 | clinicaltrials |
| NCT02581215 | Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer | completed | Phase 2 | 84 | Walid Shaib, MDOTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT03535727 | A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 48 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT04731467 | A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 79 | Famewave Ltd.INDUSTRY | 3 | Dec 27, 2024 | clinicaltrials |
| NCT03997968 | A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 169 | Cyteir Therapeutics, Inc.INDUSTRY | 1 | Dec 24, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Apr 10, 2025source: clinicaltrials